28
Johanna Adami Professor and Director and Head of Health Division VINNOVA , Swedish Government Agency for Innovation System, Sweden National perspective Sweden

EuroBioForum2014_speaker_Adami

Embed Size (px)

DESCRIPTION

EuroBioForum 3rd annual conference was held in Tallinn, Estonia, 22 + 23 September 2014

Citation preview

Page 1: EuroBioForum2014_speaker_Adami

Johanna Adami

Professor and Director and Head of Health

Division VINNOVA , Swedish Government

Agency for Innovation System, Sweden

National perspective Sweden

Page 2: EuroBioForum2014_speaker_Adami

Challenge driven innovations for

future health – a roadmap for

success

Johanna Adami, MD MPH PhD Professor

Director and Head of Health Division

Page 3: EuroBioForum2014_speaker_Adami

Sweden – A small, open

economy

• Sweden is sparsely populated. 9,7 million inhabitants…

• …but large: Surface area 450,000 km2.

• Exports: 46 percent of GDP - 30 percent services and 70 percent goods

• Foreign owned enterprises employ more than 630,000 persons. Around 13 percent of total employment.

• Foreign owned enterprises perform around 38 percent of the business R&D in Sweden.

Page 4: EuroBioForum2014_speaker_Adami

Total R&D expenditure in relation to GDP, 2011

Source: OECD, MSTI 2014

0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5

Norway

Canada

United Kingdom

China

Netherlands

Singapore

Australia

Belgium

France

Estonia

Slovenia

Iceland

USA

Austria

Switzerland (2008)

Germany

Denmark

Taiwan

Japan

Sweden

Finland

Israel

Korea

Percent of GDP

Business enterprise

Higher education

Government sector

Other organisations

Page 5: EuroBioForum2014_speaker_Adami

Sweden ranks high in innovation and competitiveness

Innovation Union Scoreboard

2014

Global Competitiveness Index

2013/2014

Switzerland Switzerland

Sweden Singapore

Denmark Finland

Germany Germany

Finland United States

Luxembourg Sweden

Netherlands Hong Kong

Belgium Netherlands

United Kingdom Japan

Ireland United Kingdom

Source: Innovation Union Scoreboard 2014 and World Economic Forum, Global Competitiveness Report 2013/14.

Page 6: EuroBioForum2014_speaker_Adami

Bild 6

Page 7: EuroBioForum2014_speaker_Adami

The Challenge

ahead

Slide 7

How to stay competetive

long term?

• Continued creation of high

productive jobs – Attract

and retain R&D activities

• Build on existing strengths

• Embrace globalization

• Removing barriers –

Innovation policy crucial

Page 8: EuroBioForum2014_speaker_Adami

National

Innovation

strategy

Bild 8

• 2020 time horizon

• Broad definition of innovation

• Focus on societal challenges

• Holistic approach to innovation and innovation support

• Innovation as a driver of national attractiveness and competitiveness

Page 9: EuroBioForum2014_speaker_Adami

VINNOVA – Sweden´s

Innovation Agency

Page 10: EuroBioForum2014_speaker_Adami

VINNOVA in brief

• VINNOVA – the Swedish

Governmental Agency for

Innovation responding to the

Ministry of Enterprise

• About 200 people work at

VINNOVA’s offices in

Stockholm, Brussels and Silicon

Valley

• Annual budget of 300 million

Euros invested in innovation

projects in all sectors in society.

Page 11: EuroBioForum2014_speaker_Adami

Three roles

Funding Research &

Innovation

National EU

Contact

Agency

Expert

Agency

Page 12: EuroBioForum2014_speaker_Adami

Funding Research and

innovation

Page 13: EuroBioForum2014_speaker_Adami

Implementation! Strategic Innovation Areas

Implementation!

EU-coordination secretariat

Implementation!

Develop the Knowledge triangle approach at universities

VINNOVA focus

Page 14: EuroBioForum2014_speaker_Adami

2014-09-26

Bild 14

Key principles of

operation

• for increased impacts of research

• broad innovation perspective;

goods, services, processes, etc.

• confidence in the actors to define

their own development strategies

• we develop and test new forms for

investments

• we develop and strengthen

beneficial international cooperation

Page 15: EuroBioForum2014_speaker_Adami

Key features of

VINNOVA programs

Funding through grants

Main funding mechanism at VINNOVA

Program period of 3-10 years

One or several open ”call-for-proposals”

Project requirements:

• Industry-relevant

• Industry-academy-research institute- public sector partners

• Co-funding, VINNOVA max. 50%

• 1-10 years projects

• Level of funding appr. € 0.3 to 10 M per project

Page 16: EuroBioForum2014_speaker_Adami

International programs

Bild 16

North and South America

USA: Road/Vehicle Safety

Innovation program

Brazil: Innovation program

Europe

EU FP7, ERAnets, INCOnets,

AAL, Artemis, Eniac, EUREKA,

COST, Eurostars, TAFTIE,

BSR

Nordic region

ICT, e-Gov’t, Transport policy

Asia

India

Life sci.y/health, ICT

Japan

Multidisciplinary Bio (JST to

2013), Network projects (JSPS)

China

ICT (concluded, Material

science, Eco-innovation

Other cooperations

South Korea, Canada, Israel:

EUREKA/Eurostars

Active government

agreement in S&T

and/or innovation

Formalized

cooperation

with budget

Bilateral program

Eureka/Eurostars

Page 17: EuroBioForum2014_speaker_Adami

We are facing a number of grand challenges

Environment Health

Ageing

population Globalization

Page 18: EuroBioForum2014_speaker_Adami

To address these challenges

You need to

• Bring world class research together

• Combine skills from many sectors

• Apply known technologies into new applications

• Utilize the best expertise from all over the world

Bild 18

opportunities

Page 20: EuroBioForum2014_speaker_Adami

Strategy for Health Innovation

Bild 20

Global re-structuring in lifescience

Global health challenges: lifestyle,

demographic changes, etc

Health care challenges; cost vs

quality – innovation potential

Weak links between high-quality

research and needs-driven

innovation

Business meets global health needs

Globally attractive

innovation system

Health care -

partner in innovation

VISION CHALLENGES

Page 21: EuroBioForum2014_speaker_Adami

Ongoing programs in health

Bild 21

Test beds

International

collaborations

Public

procurement

Collaboration

Business,

Public sector &

Academia

Innovation

hubs

Incubators

European

collaboration

programs

R&D&I

Projects

Page 22: EuroBioForum2014_speaker_Adami

Personlized medicine – some

results

VINN Cardio – biomarkers for individualized treament for

cardiovascular disease

Create Health – individualized cancer treatment

Tailored Leukapheresis for treatment of immune

mediated inflammatory diseases

Endemic diseases: To make Sweden one of the world's

leading ecosystems for life science focusing on diabetes

and other endemic diseases.

2014-09-26

Bild 22

Page 23: EuroBioForum2014_speaker_Adami

ECOSYSTEM

for health/lifescience/health care/

INDUSTRY

PATIENT

HEALTH CARE

DELIVERY

Payers/fiscal

intermediaries

Medical

technology Pharma-

ceuticals

Diagnostics

Public Private

Professional

groups

AUTHORITIES

Regulating RESEARCH/

EDUCATION Regulatory

Industry-

organisations

SME

Large

companies

s

Page 24: EuroBioForum2014_speaker_Adami

Roadmap for the future

Reform health care –public sector should be a partner in

innovation

Stimulate valuedriven innovation for all

Provide evidence for the outcomes

Work closely with regulatory agencies

Promote Incentives such as reimbursement models,

public procurement etc.

Support databases/registries

Public Private Partnership

Promote active partnership with relevant stakeholders 2014-09-26

Bild 24

Page 25: EuroBioForum2014_speaker_Adami

Collaboration is the basis for all

VINNOVA funding 2014-09-26

Bild 25

X Sectors

Research fields

Technologies

Types of Actors

Nations

Page 26: EuroBioForum2014_speaker_Adami

Connect

Catalyse

Stimulate

Page 27: EuroBioForum2014_speaker_Adami

Bild 27

Page 28: EuroBioForum2014_speaker_Adami

Thank you!

[email protected]

Bld 28